Research focused on Down syndrome has increased in the last several years to advance understanding of the consequences of trisomy 21 (T21) on molecular and cellular processes and, ultimately, on individuals with Down syndrome. The Trisomy 21 Research Society (T21RS) is the premier scientific organization for researchers and clinicians studying Down syndrome. The Third International Conference of T21RS, held June 6–9, 2019, in Barcelona, Spain, brought together 429 scientists, families, and industry representatives to share the latest discoveries on underlying cellular and molecular mechanisms of T21, define cognitive and behavioral challenges and better understand comorbidities associated with Down syndrome, including Alzheimer’s disease and leukemia. Presentation of cutting-edge results in neuroscience, neurology, model systems, psychology, cancer, biomarkers and molecular and phar­ma­cological therapeutic approaches demonstrate the compelling interest and continuing advancement in all aspects of understanding and ameliorating conditions associated with T21.
Mol Syndromol

中文翻译：

---

构建唐氏综合症的未来疗法：T21 研究学会第三届国际会议

在过去几年中，针对唐氏综合症的研究有所增加，以促进了解 21 三体 (T21) 对分子和细胞过程的影响，并最终对患有唐氏综合症的个体产生影响。21 三体研究协会 (T21RS) 是研究唐氏综合症的研究人员和临床医生的首要科学组织。第三届 T21RS 国际会议于 2019 年 6 月 6 日至 9 日在西班牙巴塞罗那举行，汇集了 429 名科学家、家庭和行业代表，分享有关 T21 潜在细胞和分子机制的最新发现，定义认知和行为挑战以及更好地了解与唐氏综合症相关的合并症，包括阿尔茨海默病和白血病。展示神经科学、神经病学、模型系统、心理学、
摩尔综合症